0000899243-21-010346.txt : 20210308 0000899243-21-010346.hdr.sgml : 20210308 20210308161519 ACCESSION NUMBER: 0000899243-21-010346 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200508 FILED AS OF DATE: 20210308 DATE AS OF CHANGE: 20210308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIDRANSKY DAVID CENTRAL INDEX KEY: 0001277161 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 21722130 MAIL ADDRESS: STREET 1: JOHNS HOPKINS UNIVERSITY STREET 2: 720 RUTLAND AVENUE CITY: BALTIMORE STATE: MD ZIP: 21205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-08 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001277161 SIDRANSKY DAVID 12/15 MOSKOVITZ ST. REHOVOT L3 7647412 ISRAEL 1 0 0 0 Common Stock 2020-05-08 4 P 0 200 15.27 A 200 I Held by Reporting Person's son Common Stock 2020-05-12 4 P 0 25 15.02 A 225 I Held by Reporting Person's son Common Stock 2020-07-07 4 P 0 1 9.60 A 226 I Held by Reporting Person's son Common Stock 2020-07-17 4 P 0 4 11.86 A 230 I Held by Reporting Person's son Common Stock 2020-08-14 4 P 0 5 11.07 A 235 I Held by Reporting Person's son Common Stock 2020-09-11 4 P 0 10 10.07 A 245 I Held by Reporting Person's son Common Stock 2020-09-14 4 P 0 1 10.70 A 246 I Held by Reporting Person's son Common Stock 2020-12-23 4 P 0 4 11.56 A 250 I Held by Reporting Person's son /s/ Roni Mamluk, Ph.D., Attorney-in-Fact for David Sidransky 2021-03-08